The COVID-19 pandemic could provide India an opportunity to scale up the healthcare industry and be a major supplier of pharmaceutical products to the world, Hindustan Unilever Chairman & Managing Director Sanjiv Mehta said on Saturday. Making a case for restarting manufacturing APIs (Active Pharmaceutical Ingredients), Mehta said this
